Opko Health, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Rubric Capital Management LP and David Rosen have jointly reported a beneficial ownership of 6.03% in OPKO Health, Inc.'s common stock, totaling 47,791,243 shares.
NASDAQ
OPKO Health, Inc. has filed a Schedule 13G, disclosing a beneficial ownership of 8.1% of Entera Bio Ltd.'s ordinary shares, totaling 3,685,226 shares, as of March 16, 2025.